Abstract
Peer Review of “COVID-19 Outcomes and Genomic Characterization of SARS-CoV-2 Isolated From Veterans in New England States: Retrospective Analysis”
Highlights
Peer Review of “COVID-19 Outcomes and Genomic Characterization of SARS-CoV-2 Isolated From Veterans in New England States: Retrospective Analysis”
Infectious disease; COVID-19; epidemiology; veteran; outcome; sequencing; genetics; virus; United States; impact; testing; severity; mortality; cohort. This is a peer-review report submitted for the paper “COVID-19 Outcomes and Genomic Characterization of SARS-CoV-2 Isolated From Veterans in New England States: Retrospective Analysis.”
The sudden menace imposed by the COVID-19 pandemic has led to the proliferation of studies on the epidemiology of viral genomics, to understand disease risk factors, characteristics, and prognosis of those with COVID-19 [1,2,3]
Summary
In 6.7 above, kindly clarify how samples were handled (including storage) If this was not done by the research team and was only reported, kindly indicate as such. In 6.9 above, it is important to report the protocol/guidelines you used in genome sequencing. You might want to report your results as follows: 1) Participant characteristics. As part of the reported results of your regression, I suggest providing an explanation on your model’s goodness of fit by plotting and reporting the area under the receiver operating characteristic curve
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
